<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-117453" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Krabbe Disease</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jain</surname>
            <given-names>Megha</given-names>
          </name>
          <aff>Maulana Azad Medical College</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>De Jesus</surname>
            <given-names>Orlando</given-names>
          </name>
          <aff>University of Puerto Rico, Medical Sciences Campus, Neurosurgery Section</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Megha Jain declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Orlando De Jesus declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>23</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-117453.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Krabbe disease, an autosomal recessive disease, is a type of lysosomal storage disorder that results from the deficiency of the enzyme galactocerebrosidase. As a result, there is an accumulation of the toxic compound psychosine, principally in the central and peripheral nervous systems, which leads to widespread neurological symptoms. Since the outcome of this disease is profound and fatal, a meticulous diagnostic work-up, followed by early treatment, is crucial. This activity reviews the evaluation and management of Krabbe disease and highlights the role of the interprofessional team in the care of patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of Krabbe disease.</p></list-item><list-item><p>Review the appropriate evaluation of Krabbe disease.</p></list-item><list-item><p>Outline the management options available for Krabbe disease.</p></list-item><list-item><p>Summarize the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by Krabbe disease.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=117453&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=117453">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-117453.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Krabbe disease is an autosomal recessive&#x000a0;neurodegenerative disorder.<xref ref-type="bibr" rid="article-117453.r1">[1]</xref><xref ref-type="bibr" rid="article-117453.r2">[2]</xref>&#x000a0;The gene mutation occurs at chromosome 14, which codes for a lysosomal hydrolase known as galactosylceramide beta hydrolase (GALC). This enzyme is responsible for metabolizing galactolipids in the central&#x000a0;nervous system and peripheral nervous system, and the failure of which will lead to the accumulation of compounds responsible for neurodegeneration. Krabbe disease is also known as globoid cell leukodystrophy because of the characteristic multinucleated globoid cells found on brain biopsy and the presence of white matter degeneration. Krabbe disease is subdivided into four subcategories based on the age of presentation of symptoms; however, many experts disagree with the age range allotted to different subtypes.<xref ref-type="bibr" rid="article-117453.r3">[3]</xref><xref ref-type="bibr" rid="article-117453.r4">[4]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Early infantile type: 0&#x000a0;to 13 months</p>
          </list-item>
          <list-item>
            <p>Late infantile type: 13&#x000a0;to 36 months</p>
          </list-item>
          <list-item>
            <p>Juvenile type:&#x000a0; 3&#x000a0;to 16 years</p>
          </list-item>
          <list-item>
            <p>Adult type: &#x0003e;16 years</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-117453.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Krabbe disease is due to loss of function gene mutation coding for galactosylceramide beta hydrolase (GALC).&#x000a0;About 200 GALC gene mutations have been identified. Usually, it is challenging to establish the phenotype severity with the genotype, but large deletions like 30 kilobase (kb) gene deletions, truncations, frameshift mutations, and nonsense mutations are associated with severe clinical manifestations.<xref ref-type="bibr" rid="article-117453.r5">[5]</xref>&#x000a0;The 30-kilobase gene deletion is common and accounts for 40% of 45% of mutations in the infantile form in Northern Europe and 35% in Mexican patients.<xref ref-type="bibr" rid="article-117453.r6">[6]</xref>&#x000a0;</p>
        <p>Approximately 50% of patients with juvenile and adult types are heterozygous for 30kb gene deletion or have mutations leading to reduced GALC enzyme activity.</p>
      </sec>
      <sec id="article-117453.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Krabbe disease is a genetic disorder, and its frequency varies widely with the population.&#x000a0;It is a rare lysosomal storage disorder that is rapidly progressive and fatal. The incidence in Europe is estimated to be 1 per 100,000 live births. After analyzing death certificates, a U.S. estimate of 1&#x000a0;per 250,000 was made, but a more precise estimate can approach the European incidence.<xref ref-type="bibr" rid="article-117453.r7">[7]</xref></p>
        <p>Its rate is as high as 6 per 1000 live births in Israel's Druze community due to consanguineous marriages. Among the four subtypes,&#x000a0;85%&#x000a0;to 90% of the cases are of the infantile subtype, which is also the most severe and rapidly progressing. The mortality rate is as high as 90% in the first two years of life. The late-onset type has a better prognosis, and life expectancy is 5&#x000a0;to 7 years after the&#x000a0;onset&#x000a0;of symptoms.</p>
      </sec>
      <sec id="article-117453.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Krabbe disease is due to the GALC enzyme deficiency, present in the lysosomes of microglial cells of the brain and the spinal cord. Microglia cells are responsible for the physiological turnover of myelin components and the elimination of toxic compounds. GALC metabolizes two galactolipids, galactosylceramide, and psychosine.&#x000a0;Galactosylceramide is present in high concentrations in Schwann cells and oligodendroglial cells. GALC degrades galactosylceramide; its deficiency leads to the building up of galactosylceramide in the central and&#x000a0;peripheral nervous system.&#x000a0;Psychosine is a cytotoxic sphingosine lipid formed as a byproduct during myelin synthesis.<xref ref-type="bibr" rid="article-117453.r8">[8]</xref><xref ref-type="bibr" rid="article-117453.r9">[9]</xref></p>
        <p>The mechanism of how the accumulation of psychosine manifests its cytotoxic effect on oligodendroglia is unclear. Multiple hypotheses, like the microglia hypothesis and the psychosine hypothesis, have been formulated. The accumulation of these two compounds in the oligodendrocytes and Schwann cells leads to apoptosis of these cells and, hence, demyelination. In turn, the apoptosis leads to secondary activation of microglial cells and its transformation into multinucleated giant cells known as globoid cells, which are pathognomic of Krabbe disease.</p>
      </sec>
      <sec id="article-117453.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Blood vessels will have clusters of multinucleated macrophages with abundant cytoplasm (globoid cells).<xref ref-type="bibr" rid="article-117453.r1">[1]</xref>&#x000a0;Neuronal degeneration at the gray matter is found. Hypomyelination and&#x000a0;segmental demyelination occur in the early and late-onset forms, respectively. Curvilinear lamellar inclusions can be seen in Schwann cells and histiocytes on electron microscopy.</p>
      </sec>
      <sec id="article-117453.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The severity&#x000a0;of the symptoms depends on the age of presentation of symptoms. The infantile disease is rapidly progressive and fatal by age 2. Late-onset disease has relatively milder symptoms and longer life expectancy.<xref ref-type="bibr" rid="article-117453.r10">[10]</xref><xref ref-type="bibr" rid="article-117453.r11">[11]</xref><xref ref-type="bibr" rid="article-117453.r12">[12]</xref></p>
        <p>Infantile disease:&#x000a0;The symptom progression is best explained by categorizing it into stages.<xref ref-type="bibr" rid="article-117453.r11">[11]</xref><xref ref-type="bibr" rid="article-117453.r12">[12]</xref><xref ref-type="bibr" rid="article-117453.r13">[13]</xref><xref ref-type="bibr" rid="article-117453.r14">[14]</xref><xref ref-type="bibr" rid="article-117453.r15">[15]</xref><xref ref-type="bibr" rid="article-117453.r16">[16]</xref></p>
        <p>Stage 1- The child grows well until 4&#x000a0;to 6 months of age, when the clinical illness manifests. The symptoms commence with restlessness, irritability, vomiting, feeding difficulty, and failure to thrive. The child may be hypersensitive to touch, noise, or bright light and can develop tonic spasms in the presence of these instigating factors.</p>
        <p>Stage 2- The child develops visual difficulty, optic atrophy, and opisthotonic posturing. They experience seizure-like episodes that have to be differentiated from epilepsy as these don't respond to anticonvulsants.</p>
        <p>Stage 3- The most debilitating form of the disease is when the child develops blindness, deafness, and decerebrate posturing. Spasticity can be severe enough to halt any voluntary movement.<xref ref-type="bibr" rid="article-117453.r15">[15]</xref></p>
        <p>Late infantile disease:&#x000a0;Manifests between 13&#x000a0;to 36 months of age with irritability, visual difficulties, and abnormal gait. As the condition progresses, these symptoms worsen with the development of seizures, apneic episodes, and temperature instability. The median age of mortality is usually six years.<xref ref-type="bibr" rid="article-117453.r4">[4]</xref></p>
        <p>Juvenile onset disease:<bold>&#x000a0;</bold>The child develops visual difficulties, tremors, gait abnormalities, and attention deficit hyperactivity disorder. The rate of progression of the disease is highly variable, but the disease eventually debilitates&#x000a0;the patient, and they die within ten years of the diagnosis.</p>
        <p>Late-onset disease:&#x000a0;Characterized by burning paresthesias in the extremities, mood and behavior alterations, ataxia, spasticity, visual difficulty/blindness, seizures, hearing loss/deafness, and psychomotor retardation. The patients can present with motor and sensory neuropathy associated with muscular atrophy and scoliosis. Few patients present with symptoms confined to a physical weakness without intellectual disability; on the other hand, others deteriorate both mentally and physically.<xref ref-type="bibr" rid="article-117453.r17">[17]</xref><xref ref-type="bibr" rid="article-117453.r18">[18]</xref></p>
      </sec>
      <sec id="article-117453.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Newborn Screening</bold>
</p>
        <p>Many states in the U.S. include screening for Krabbe disease in a standard newborn screening protocol. The initial screening test involves measuring the GALC&#x000a0;enzyme activity in the peripheral leukocytes or cultured skin fibroblasts.<xref ref-type="bibr" rid="article-117453.r19">[19]</xref><xref ref-type="bibr" rid="article-117453.r20">[20]</xref>&#x000a0;Values falling below 5% of the normal range confirm the diagnosis. However, it does not correlate with the severity of disease manifestation. This screening method's specificity is low; therefore, a second tier of the screening method is added to help identify the true positives. It can either be measuring blood psychosine levels or performing&#x000a0;sequencing for the GALC gene. The high levels of psychosine are indicative of infantile Krabbe's disease. As not all laboratories are equipped&#x000a0;to detect all GALC gene mutations and multiple variants of GALC mutations of unknown significance, measuring psychosine levels is more feasible and reliable.<xref ref-type="bibr" rid="article-117453.r9">[9]</xref><xref ref-type="bibr" rid="article-117453.r21">[21]</xref><xref ref-type="bibr" rid="article-117453.r22">[22]</xref><xref ref-type="bibr" rid="article-117453.r23">[23]</xref></p>
        <p>
<bold>Imaging Studies</bold>
</p>
        <p>Computed tomographic scan: Initially shows symmetrical hyperdense areas (due to demyelination) in the cerebellum, cerebrum, thalamus, brainstem, internal capsule, and corona radiata. Later in the course, hypodense areas (due to atrophy) develop in the corona radiata, and cerebral/cerebellar atrophy develops.</p>
        <p>Magnetic resonance imaging: It is particularly useful&#x000a0;in&#x000a0;identifying brain lesions in Krabbe disease. In the infantile forms, there is increased T2 signal intensity in deep cerebral white matter, dentate nucleus, and cerebellar white matter. In juvenile and adult disease, there is increased T2 signal intensity in the parieto-occipital regions and the corticospinal tracts; the dentate nuclei and the cerebellar white matter are usually spared.<xref ref-type="bibr" rid="article-117453.r13">[13]</xref><xref ref-type="bibr" rid="article-117453.r24">[24]</xref><xref ref-type="bibr" rid="article-117453.r25">[25]</xref>&#x000a0;There is no contrast enhancement in the affected areas; however, optic nerve and peripheral nerve (e.g., lumbosacral plexus) thickening and enhancement can be seen.</p>
        <p>
<bold>Magnetic Resonance Spectroscopy</bold>
</p>
        <p>The centrum semiovale may show raised choline levels in the adult subtype.<xref ref-type="bibr" rid="article-117453.r26">[26]</xref></p>
        <p>Electroencephalography</p>
        <p>May show epileptiform activity. Generalized slowing or disorganized rhythms are expected.</p>
        <p>
<bold>Ophthalmologic and Otolaryngologist Evaluation</bold>
</p>
        <p>The child needs an otolaryngologist assessment and an eye examination to determine the degree of hearing and vision loss and to provide hearing and vision aids to the patient.</p>
        <p>
<bold>Genetic Testing</bold>
</p>
        <p>Molecular genetic analysis is crucial, as it identifies carriers within a family. It also identifies at-risk pregnancies, and, in some cases, predicts the phenotype based on detected genotype.</p>
        <p>
<bold>Lumbar Puncture</bold>
</p>
        <p>A lumbar puncture may reveal elevated cerebrospinal fluid (CSF) protein levels and an abnormal protein electrophoretic pattern. The protein analysis demonstrates an increase in albumin and alpha-1 globulin levels and decreased beta-1 globulin and gamma globulin levels. CSF protein levels greater than 61.5mg/dl are associated with low/shorter survival.</p>
        <p>
<bold>Electromyography and Nerve Conduction Studies</bold>
</p>
        <p>Electromyography changes are usually consistent with peripheral neuropathy. There is a significant slowing of conduction velocity in both motor and sensory nerves in most patients with the infantile type of disease and about 20% of patients with the late-onset Krabbe disease.</p>
        <p><bold>Brain Biopsy</bold>&#x000a0;</p>
        <p>The pathology findings show demyelination of white matter, loss of oligodendroglial cells, and areas of atrophy. The classical multinucleated globoid cells can be demonstrated on the periodic acid-Schiff stain.<xref ref-type="bibr" rid="article-117453.r11">[11]</xref></p>
      </sec>
      <sec id="article-117453.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Currently, the therapeutic options are limited to asymptomatic or minimally symptomatic patients with Krabbe disease's infantile form.</p>
        <p>
<bold>Hematopoietic Stem Cell Transplant (HSCT)</bold>
</p>
        <p>The hematopoietic cells from a healthy donor are transplanted to the patient. HSCT helps the patient to populate the brain with microglia with normal function and good GALC enzyme activity. HSCT works best before the onset of symptoms and helps plateau or slow its progression. Studies have shown its efficacy in halting the cognitive and motor decline in the patient.<xref ref-type="bibr" rid="article-117453.r27">[27]</xref><xref ref-type="bibr" rid="article-117453.r28">[28]</xref><xref ref-type="bibr" rid="article-117453.r29">[29]</xref><xref ref-type="bibr" rid="article-117453.r30">[30]</xref><xref ref-type="bibr" rid="article-117453.r31">[31]</xref>&#x000a0;</p>
        <p>A study focused on diffusion tensor imaging in patients with Krabbe disease demonstrated that HSCT reduces the fraction anisotropy (FA) across six tracts measured. The decrease in FA in corticospinal tracts is associated with better cognitive and motor outcomes. A reduction in FA in the splenium and uncinate fasciculus is correlated with better cognitive outcomes.<xref ref-type="bibr" rid="article-117453.r32">[32]</xref>&#x000a0;The risk factors associated with HSCT&#x000a0;are due to the chemotherapy the patient receives to limit the donor stem cells' immune rejection. There is ongoing research to make this treatment safer for the patient and with fewer side effects.</p>
        <p>
<bold>Cord Blood Stem Cell Transfusion</bold>
</p>
        <p>Cord blood stem cells collected from an unrelated donor's umbilical cord are transfused into the patient. However, this procedure has also been beneficial to only those patients treated before symptoms appear.<xref ref-type="bibr" rid="article-117453.r16">[16]</xref></p>
        <p>
<bold>Supportive</bold>
</p>
        <p>More research is required to find better treatment options for patients suffering from Krabbe disease. Until then, the patient can be provided with supportive care.</p>
        <list list-type="bullet">
          <list-item>
            <p>Muscle relaxants for spasms</p>
          </list-item>
          <list-item>
            <p>Anticonvulsants might sometimes be helpful for seizures</p>
          </list-item>
          <list-item>
            <p>Physiotherapy to increase mobility</p>
          </list-item>
          <list-item>
            <p>Occupational therapy for children to improve motor function</p>
          </list-item>
          <list-item>
            <p>Speech therapy to maintain swallowing functioning and maximize communication</p>
          </list-item>
          <list-item>
            <p>Tube feedings for good nutrition if swallowing is affected</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-117453.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of infantile Krabbe disease is broad and includes several neurodegenerative conditions that can present with neurodevelopmental delay and white matter abnormalities on neuroimaging studies:<xref ref-type="bibr" rid="article-117453.r33">[33]</xref><xref ref-type="bibr" rid="article-117453.r34">[34]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Alexander disease</p>
          </list-item>
          <list-item>
            <p>Canavan disease</p>
          </list-item>
          <list-item>
            <p>GM2 gangliosidoses</p>
          </list-item>
          <list-item>
            <p>Metachromatic leukodystrophy</p>
          </list-item>
          <list-item>
            <p>Sphingomyelinase deficiency</p>
          </list-item>
        </list>
        <p>Although distinguishing Krabbe disease from the disorders mentioned above can be challenging, a definitive diagnosis can be made based on targeted metabolic and molecular genetic testing.<xref ref-type="bibr" rid="article-117453.r33">[33]</xref></p>
      </sec>
      <sec id="article-117453.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The average lifespan in patients with infantile Krabbe disease is 13 months. Most patients with late infantile&#x000a0;disease die within two years of disease onset. The progression of disease and lifespan reduction vary in both juvenile-onset and adult-onset Krabbe disease. HSCT markedly improves short-term survival for individuals treated while asymptomatic during the early neonatal period.<xref ref-type="bibr" rid="article-117453.r30">[30]</xref><xref ref-type="bibr" rid="article-117453.r35">[35]</xref></p>
      </sec>
      <sec id="article-117453.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The disease is usually fatal. Most infantile cases die by two years of age, late infantile&#x000a0;within two years of disease onset,&#x000a0;and juvenile cases within ten years of diagnosis. It has a multitude of complications that debilitate the patient, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Deafness</p>
          </list-item>
          <list-item>
            <p>Vision loss</p>
          </list-item>
          <list-item>
            <p>Rigid posture</p>
          </list-item>
          <list-item>
            <p>Cognitive deterioration</p>
          </list-item>
          <list-item>
            <p>Aspiration leading to infections</p>
          </list-item>
          <list-item>
            <p>Respiratory failure due to poor muscle tone</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-117453.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>The patient needs a multifaceted approach tailored to their needs.</p>
        <list list-type="bullet">
          <list-item>
            <p>Neurologist</p>
          </list-item>
          <list-item>
            <p>Ophthalmologist</p>
          </list-item>
          <list-item>
            <p>Otolaryngologist</p>
          </list-item>
          <list-item>
            <p>Geneticist</p>
          </list-item>
          <list-item>
            <p>Physiotherapist</p>
          </list-item>
          <list-item>
            <p>Occupational therapist</p>
          </list-item>
          <list-item>
            <p>Social worker</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-117453.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>As it is an incapacitating disease, both patients and caretakers should be educated about the disease's genetic nature, its complications, prognosis, and the necessity of early intervention. They should be informed that a team of care providers will work with them to achieve the best possible outcomes. Genetic testing should also be offered to all parents of children suffering from Krabbe disease to understand the risk of future pregnancies being affected and have options to avoid it.<xref ref-type="bibr" rid="article-117453.r27">[27]</xref><xref ref-type="bibr" rid="article-117453.r30">[30]</xref></p>
      </sec>
      <sec id="article-117453.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Krabbe disease involves multiple systems, and therefore, the best outcomes can be achieved with an&#x000a0;interprofessional&#x000a0;approach with a team of clinicians, therapists, and social workers&#x000a0;involved. As the disease symptoms present similarly to other leukodystrophies, prompt and accurate diagnosis is essential for an appropriate management plan. It is important to note that treatment for Krabbe disease works best when commenced before the onset of symptoms; therefore, a clinician's vigilance is essential to pick up symptoms in their early stages. Also, screening newborns can help in early identification and early intervention.</p>
        <p>An interprofessional team of specialists is employed, including a geneticist, neurologist, ophthalmologist, audiometrist, and physiotherapist. The geneticist can help the families understand the disease outcome, risk recurrence, and prenatal testing. The neurologist can provide symptomatic treatment and documentation of neurological sequelae. The social worker can assess the level of care at home and provide options to facilitate it further.</p>
      </sec>
      <sec id="article-117453.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=117453&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=117453">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/neurology/krabbe-disease/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=117453">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/117453/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=117453">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-117453.s17">
        <title>References</title>
        <ref id="article-117453.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suzuki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>1970</year>
            <month>Jun</month>
            <volume>66</volume>
            <issue>2</issue>
            <fpage>302</fpage>
            <page-range>302-9</page-range>
            <pub-id pub-id-type="pmid">5271165</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Graziano</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Cardile</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>History, genetic, and recent advances on Krabbe disease.</article-title>
            <source>Gene</source>
            <year>2015</year>
            <month>Jan</month>
            <day>15</day>
            <volume>555</volume>
            <issue>1</issue>
            <fpage>2</fpage>
            <page-range>2-13</page-range>
            <pub-id pub-id-type="pmid">25260228</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suzuki</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Globoid cell leukodystrophy (Krabbe's disease): update.</article-title>
            <source>J Child Neurol</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>18</volume>
            <issue>9</issue>
            <fpage>595</fpage>
            <page-range>595-603</page-range>
            <pub-id pub-id-type="pmid">14572137</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bascou</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>DeRenzo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Poe</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Escolar</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>A prospective natural history study of Krabbe disease in a patient cohort with onset between 6&#x000a0;months and 3&#x000a0;years of life.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2018</year>
            <month>Aug</month>
            <day>09</day>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>126</fpage>
            <pub-id pub-id-type="pmid">30089515</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luzi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rafi</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Wenger</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Structure and organization of the human galactocerebrosidase (GALC) gene.</article-title>
            <source>Genomics</source>
            <year>1995</year>
            <month>Mar</month>
            <day>20</day>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>407</fpage>
            <page-range>407-9</page-range>
            <pub-id pub-id-type="pmid">7601472</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rafi</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Luzi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>YQ</given-names>
              </name>
              <name>
                <surname>Wenger</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>A large deletion together with a point mutation in the GALC gene is a common mutant allele in patients with infantile Krabbe disease.</article-title>
            <source>Hum Mol Genet</source>
            <year>1995</year>
            <month>Aug</month>
            <volume>4</volume>
            <issue>8</issue>
            <fpage>1285</fpage>
            <page-range>1285-9</page-range>
            <pub-id pub-id-type="pmid">7581365</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barczykowski</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Foss</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Duffner</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Death rates in the U.S. due to Krabbe disease and related leukodystrophy and lysosomal storage diseases.</article-title>
            <source>Am J Med Genet A</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>158A</volume>
            <issue>11</issue>
            <fpage>2835</fpage>
            <page-range>2835-42</page-range>
            <pub-id pub-id-type="pmid">22991292</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>CLELAND</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>KENNEDY</surname>
                <given-names>EP</given-names>
              </name>
            </person-group>
            <article-title>The enzymatic synthesis of psychosine.</article-title>
            <source>J Biol Chem</source>
            <year>1960</year>
            <month>Jan</month>
            <volume>235</volume>
            <fpage>45</fpage>
            <page-range>45-51</page-range>
            <pub-id pub-id-type="pmid">13810623</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Turgeon</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Orsini</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Sanders</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Magera</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Langan</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Escolar</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Duffner</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Oglesbee</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gavrilov</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tortorelli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rinaldo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Raymond</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Matern</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Measurement of psychosine in dried blood spots--a possible improvement to newborn screening programs for Krabbe disease.</article-title>
            <source>J Inherit Metab Dis</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>38</volume>
            <issue>5</issue>
            <fpage>923</fpage>
            <page-range>923-9</page-range>
            <pub-id pub-id-type="pmid">25762404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Korn-Lubetzki</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Dor-Wollman</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Soffer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Raas-Rothschild</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hurvitz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nevo</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Early peripheral nervous system manifestations of infantile Krabbe disease.</article-title>
            <source>Pediatr Neurol</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>115</fpage>
            <page-range>115-8</page-range>
            <pub-id pub-id-type="pmid">12699861</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Komatsuzaki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zielonka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mountford</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>K&#x000f6;lker</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hoffmann</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Garbade</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Ries</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Clinical characteristics of 248 patients with Krabbe disease: quantitative natural history modeling based on published cases.</article-title>
            <source>Genet Med</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>21</volume>
            <issue>10</issue>
            <fpage>2208</fpage>
            <page-range>2208-2215</page-range>
            <pub-id pub-id-type="pmid">30899093</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dunn</surname>
                <given-names>HG</given-names>
              </name>
              <name>
                <surname>Lake</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Dolman</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The neuropathy of Krabbe's infantile cerebral sclerosis (globoid cell leucodystrophy).</article-title>
            <source>Brain</source>
            <year>1969</year>
            <volume>92</volume>
            <issue>2</issue>
            <fpage>329</fpage>
            <page-range>329-44</page-range>
            <pub-id pub-id-type="pmid">5790252</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duffner</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Barczykowski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jalal</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kay</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Early infantile Krabbe disease: results of the World-Wide Krabbe Registry.</article-title>
            <source>Pediatr Neurol</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>45</volume>
            <issue>3</issue>
            <fpage>141</fpage>
            <page-range>141-8</page-range>
            <pub-id pub-id-type="pmid">21824559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duffner</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Jalal</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>The Hunter's Hope Krabbe family database.</article-title>
            <source>Pediatr Neurol</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>40</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-8</page-range>
            <pub-id pub-id-type="pmid">19068248</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beltran-Quintero</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Bascou</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Poe</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Wenger</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Saavedra-Matiz</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Nichols</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Escolar</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Early progression of Krabbe disease in patients with symptom onset between 0 and 5&#x02009;months.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2019</year>
            <month>Feb</month>
            <day>18</day>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>46</fpage>
            <pub-id pub-id-type="pmid">30777126</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Escolar</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Poe</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Kurtzberg</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>A staging system for infantile Krabbe disease to predict outcome after unrelated umbilical cord blood transplantation.</article-title>
            <source>Pediatrics</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>118</volume>
            <issue>3</issue>
            <fpage>e879</fpage>
            <page-range>e879-89</page-range>
            <pub-id pub-id-type="pmid">16923928</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kolodny</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Raghavan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Krivit</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Late-onset Krabbe disease (globoid cell leukodystrophy): clinical and biochemical features of 15 cases.</article-title>
            <source>Dev Neurosci</source>
            <year>1991</year>
            <volume>13</volume>
            <issue>4-5</issue>
            <fpage>232</fpage>
            <page-range>232-9</page-range>
            <pub-id pub-id-type="pmid">1817026</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marks</surname>
                <given-names>HG</given-names>
              </name>
              <name>
                <surname>Scavina</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Kolodny</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Palmieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Childs</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Krabbe's disease presenting as a peripheral neuropathy.</article-title>
            <source>Muscle Nerve</source>
            <year>1997</year>
            <month>Aug</month>
            <volume>20</volume>
            <issue>8</issue>
            <fpage>1024</fpage>
            <page-range>1024-8</page-range>
            <pub-id pub-id-type="pmid">9236794</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farrell</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Percy</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Kaback</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>McKhann</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>Globoid cell (Krabbe's) leukodystrophy: heterozygote detection in cultured skin fibroblasts.</article-title>
            <source>Am J Hum Genet</source>
            <year>1973</year>
            <month>Nov</month>
            <volume>25</volume>
            <issue>6</issue>
            <fpage>604</fpage>
            <page-range>604-9</page-range>
            <pub-id pub-id-type="pmid">4773478</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Camelier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Civallero</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>De Mari</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Burin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Giugliani</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Galactocerebrosidase assay on dried-leukocytes impregnated in filter paper for the detection of Krabbe disease.</article-title>
            <source>Clin Chim Acta</source>
            <year>2015</year>
            <month>Jan</month>
            <day>01</day>
            <volume>438</volume>
            <fpage>178</fpage>
            <page-range>178-80</page-range>
            <pub-id pub-id-type="pmid">25193740</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Orsini</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Kay</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Saavedra-Matiz</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Wenger</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Duffner</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Erbe</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Biski</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Krein</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Nichols</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kurtzberg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Escolar</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Arnold</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Iglesias</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Galvin-Parton</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kronn</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Pellegrino</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Shur</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Wasserstein</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Caggana</surname>
                <given-names>M</given-names>
              </name>
              <collab>New York State Krabbe Disease Consortium</collab>
            </person-group>
            <article-title>Newborn screening for Krabbe disease in New York State: the first eight years' experience.</article-title>
            <source>Genet Med</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>239</fpage>
            <page-range>239-48</page-range>
            <pub-id pub-id-type="pmid">26795590</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wenger</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Sattler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>McKelvey</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>An improved method for the identification of patients and carriers of Krabbe's disease.</article-title>
            <source>Clin Chim Acta</source>
            <year>1974</year>
            <month>Oct</month>
            <day>30</day>
            <volume>56</volume>
            <issue>2</issue>
            <fpage>199</fpage>
            <page-range>199-206</page-range>
            <pub-id pub-id-type="pmid">4434632</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meikle</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Ranieri</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Simonsen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Rozaklis</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ramsay</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Whitfield</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Fuller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Christensen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Skovby</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hopwood</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Newborn screening for lysosomal storage disorders: clinical evaluation of a two-tier strategy.</article-title>
            <source>Pediatrics</source>
            <year>2004</year>
            <month>Oct</month>
            <volume>114</volume>
            <issue>4</issue>
            <fpage>909</fpage>
            <page-range>909-16</page-range>
            <pub-id pub-id-type="pmid">15466084</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Enzmann</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Infantile Krabbe disease: complementary CT and MR findings.</article-title>
            <source>AJNR Am J Neuroradiol</source>
            <year>1993</year>
            <season>Sep-Oct</season>
            <volume>14</volume>
            <issue>5</issue>
            <fpage>1164</fpage>
            <page-range>1164-6</page-range>
            <pub-id pub-id-type="pmid">8237697</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tokushige</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sonoo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Maekawa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shirota</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hanajima</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Terao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Matsumoto</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hossain</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Sakai</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Shiio</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Isolated pyramidal tract impairment in the central nervous system of adult-onset Krabbe disease with novel mutations in the GALC gene.</article-title>
            <source>Brain Dev</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>35</volume>
            <issue>6</issue>
            <fpage>579</fpage>
            <page-range>579-81</page-range>
            <pub-id pub-id-type="pmid">22959700</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brockmann</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dechent</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wilken</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rusch</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Frahm</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hanefeld</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Proton MRS profile of cerebral metabolic abnormalities in Krabbe disease.</article-title>
            <source>Neurology</source>
            <year>2003</year>
            <month>Mar</month>
            <day>11</day>
            <volume>60</volume>
            <issue>5</issue>
            <fpage>819</fpage>
            <page-range>819-25</page-range>
            <pub-id pub-id-type="pmid">12629240</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Langan</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Barcykowski</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Dare</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pannullo</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Muscarella</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Evidence for improved survival in postsymptomatic stem cell-transplanted patients with Krabbe's disease.</article-title>
            <source>J Neurosci Res</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>94</volume>
            <issue>11</issue>
            <fpage>1189</fpage>
            <page-range>1189-94</page-range>
            <pub-id pub-id-type="pmid">27638603</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allewelt</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Taskindoust</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Troy</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Page</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Parikh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Prasad</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Kurtzberg</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Long-Term Functional Outcomes after Hematopoietic Stem Cell Transplant for Early Infantile Krabbe Disease.</article-title>
            <source>Biol Blood Marrow Transplant</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>24</volume>
            <issue>11</issue>
            <fpage>2233</fpage>
            <page-range>2233-2238</page-range>
            <pub-id pub-id-type="pmid">29933067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Escolar</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Poe</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Provenzale</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Richards</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Allison</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wenger</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Pietryga</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wall</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Champagne</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Morse</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Krivit</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kurtzberg</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease.</article-title>
            <source>N Engl J Med</source>
            <year>2005</year>
            <month>May</month>
            <day>19</day>
            <volume>352</volume>
            <issue>20</issue>
            <fpage>2069</fpage>
            <page-range>2069-81</page-range>
            <pub-id pub-id-type="pmid">15901860</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krivit</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Shapiro</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Peters</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Cornu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kurtzberg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wenger</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Kolodny</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Vanier</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Loes</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Dusenbery</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lockman</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy.</article-title>
            <source>N Engl J Med</source>
            <year>1998</year>
            <month>Apr</month>
            <day>16</day>
            <volume>338</volume>
            <issue>16</issue>
            <fpage>1119</fpage>
            <page-range>1119-26</page-range>
            <pub-id pub-id-type="pmid">9545360</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wright</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Poe</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>DeRenzo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Haldal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Escolar</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Developmental outcomes of cord blood transplantation for Krabbe disease: A 15-year study.</article-title>
            <source>Neurology</source>
            <year>2017</year>
            <month>Sep</month>
            <day>26</day>
            <volume>89</volume>
            <issue>13</issue>
            <fpage>1365</fpage>
            <page-range>1365-1372</page-range>
            <pub-id pub-id-type="pmid">28855403</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Poe</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Styner</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Panigrahy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Escolar</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Regional differences in fiber tractography predict neurodevelopmental outcomes in neonates with infantile Krabbe disease.</article-title>
            <source>Neuroimage Clin</source>
            <year>2015</year>
            <volume>7</volume>
            <fpage>792</fpage>
            <page-range>792-8</page-range>
            <pub-id pub-id-type="pmid">25844309</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schiffmann</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>van der Knaap</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Invited article: an MRI-based approach to the diagnosis of white matter disorders.</article-title>
            <source>Neurology</source>
            <year>2009</year>
            <month>Feb</month>
            <day>24</day>
            <volume>72</volume>
            <issue>8</issue>
            <fpage>750</fpage>
            <page-range>750-9</page-range>
            <pub-id pub-id-type="pmid">19237705</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gelinas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Liao</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lehman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stockler</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sirrs</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Child Neurology: Krabbe disease: a potentially treatable white matter disorder.</article-title>
            <source>Neurology</source>
            <year>2012</year>
            <month>Nov</month>
            <day>06</day>
            <volume>79</volume>
            <issue>19</issue>
            <fpage>e170</fpage>
            <page-range>e170-2</page-range>
            <pub-id pub-id-type="pmid">23128445</pub-id>
          </element-citation>
        </ref>
        <ref id="article-117453.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tokimasa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ohta</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Takizawa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kusuki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hashii</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sakai</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Taniike</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ozono</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hara</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Umbilical cord-blood transplantations from unrelated donors in patients with inherited metabolic diseases: Single-institute experience.</article-title>
            <source>Pediatr Transplant</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>12</volume>
            <issue>6</issue>
            <fpage>672</fpage>
            <page-range>672-6</page-range>
            <pub-id pub-id-type="pmid">18798361</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
